Haploid Induction via Lipid Compounds and PLA2 Gene Modification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for inducing haploid production in plants, such as maize, are inefficient, with low haploid induction rates and high embryo abortion and fertilization failure rates, limiting the production of doubled haploid lines which are crucial for rapid generation of homozygous inbred lines.
Innovation Solution
The use of specific lipid compounds like methyl alpha linolenyl fluorophosphonate (MALFP), arachidonyl fluorophosphonate, and 1,2-distearoyl-sn-glycero-3-phosphatidyl choline (DSPC) applied to reproductive tissues during pollination to induce de novo haploid production, and the identification and modification of the patatin-like phospholipase A2 (PLA2) gene to enhance haploid induction rates.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional haploid induction methods are used, then haploid production can be achieved, but the induction rate is low and embryo abortion rate is high
Solution Approach 1:
The patent modifies the PLA2 gene sequence to create mutant versions with altered phospholipase activity. Specific amino acid substitutions (e.g., H196Y, K198R) change the enzyme's catalytic properties, thereby altering the haploid induction mechanism to reduce embryo abortion while maintaining or enhancing induction rates
Solution Approach 2:
The patent creates multiple copies of the mutated PLA2 gene and introduces them into plant genomes. These copied mutant genes are expressed to produce the modified phospholipase enzyme that drives improved haploid induction. The copying principle is applied by transferring the mutant gene sequence into plant cells where it is replicated and expressed
2Stability of the object's composition
If self-pollination is used to develop homozygous inbred lines, then genetic homogeneity can be achieved, but the process requires numerous generations and is time consuming
Solution Approach 1:
The patent performs preliminary haploid induction through pollination with mutant PLA2-expressing pollen before the plant completes its normal development cycle. By inducing haploidy at an early stage, the subsequent chromosome doubling produces homozygous lines in a single generation rather than requiring multiple generations of self-pollination to achieve the same genetic homogeneity
Solution Approach 2:
The patent exploits the phase transition from diploid to haploid state through controlled chromosome number reduction. By inducing a phase transition to haploidy and then doubling chromosomes to reach a stable homozygous diploid state, the method achieves rapid generation of inbred lines that would otherwise require lengthy sequential self-pollination cycles
3Productivity
If chromosome doubling agents like colchicine are used, then haploid plants can be converted to doubled haploid homozygous inbred lines, but the process efficiency is limited
Solution Approach 1:
The patent uses the mutated PLA2 gene and its encoded phospholipase enzyme as an intermediary agent to mediate haploid induction. This biological intermediary replaces or complements chemical chromosome doubling agents, providing a more efficient and controllable method for producing doubled haploid lines. The intermediary enables precise temporal and spatial control of the induction process
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Significantly increases the haploid induction rate and reduces embryo abortion, allowing for higher frequencies of haploid seed production and improved kernel formation, thereby facilitating the generation of doubled haploid lines more efficiently.
Implementation Method 1
The use of specific lipid compounds like methyl alpha linolenyl fluorophosphonate (MALFP), arachidonyl fluorophosphonate, and 1,2-distearoyl-sn-glycero-3-phosphatidyl choline (DSPC) applied to reproductive tissues during pollination to induce de novo haploid production
Implementation Method 2
the identification and modification of the patatin-like phospholipase A2 (PLA2) gene to enhance haploid induction rates
Data Source
Figure 1
Figure 2a
Figure 3
AI summary
Provided here are methods of using a mutated patatin-like phospholipase IIα ("pPLAIIα," renamed here MATRILINEAL) to induce haploid induction in plants, cloning a pPLAIIα to induce haploid induction in plants, and genetically engineering a plant to contain a mutated pPLAIIα. Also provided are methods of applying topical and spray chemicals, lipids, and RNAi molecules to plants during pollination in order to induce haploid production. Further provided are methods of chemically treating plants during pollination to induce haploids while also reducing embryo abortion and increasing seed set.